Neuraminidase Inhibitor Market Size And Share

  • Report Code : TIPRE00016378
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Neuraminidase Inhibitor Market Report - Size and Share 2031

Buy Now

Neuraminidase Inhibitor Market Report Neuraminidase Inhibitor Market Scope and Analysis Neuraminidase Inhibitor Market Size and Share

Neuraminidase Inhibitor Market Report Analysis

Neuraminidase Inhibitor Market

  • CAGR (2025 - 2031)
    5%
  • Market Size 2024
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Strides Consumer LLC
  • BioCryst Pharmaceuticals Inc
  • Teva Pharmaceuticals Industries Ltd
  • NATCO Pharma Limited
  • Alvogen
  • Amneal Pharmaceuticals LLC
  • Macleods Pharmaceuticals Ltd
  • F Hoffmann La Roche Ltd
  • GlaxoSmithKline Plc

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Indication
  • Influenza Virus A
  • Influenza Virus B
By Drug Type
  • Zanamivir
  • Oseltamivir
  • Peramivir
  • Laninamivir
By Route of Administration
  • Parenteral
  • Oral
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy